Kelly Blackburn
CIK: 0001640575
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRVO
CervoMed Inc.
Officer
Discretionary Trading P&L
Holdings
About Blackburn Kelly
Blackburn Kelly (SEC CIK 0001640575) files insider reports with the SEC as EVP, Clinical Development of CervoMed Inc. (CRVO).
Signal8 holds 3 ownership filings by Blackburn Kelly, all Form 4s, filed between Feb 14, 2025 and Oct 23, 2026. Those filings report 3 transactions, from Feb 4, 2025 to Oct 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Blackburn Kelly's filings is in BOSTON, MA.
Recent filings by Blackburn Kelly
Other insiders filing for CervoMed Inc. (CRVO)
- De Rosch Mark, EVP, RA and GA and PgM
- Winton Matthew, Chief Commercial and Business
- BOGER JOSHUA S, Director
- ZAVRL FRANK, Director
- Sabbagh Marwan, Director
- Quigley David, Director